Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade.

Hitz F, Diem S, Haile SR, Ess S, Cerny T, Mey U.

Hematol Oncol. 2014 Dec;32(4):192-6. doi: 10.1002/hon.2123. Epub 2013 Dec 11.

PMID:
24338732
2.

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M, Stilgenbauer S, Thieblemont C, Hallek M, Forstpointner R, Pott C, Ribrag V, Doorduijn J, Hiddemann W, Dreyling MH, Unterhalt M.

J Clin Oncol. 2014 May 1;32(13):1338-46. doi: 10.1200/JCO.2013.52.2466. Epub 2014 Mar 31.

3.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

Pott C, Hoster E, Delfau-Larue MH, Beldjord K, Böttcher S, Asnafi V, Plonquet A, Siebert R, Callet-Bauchu E, Andersen N, van Dongen JJ, Klapper W, Berger F, Ribrag V, van Hoof AL, Trneny M, Walewski J, Dreger P, Unterhalt M, Hiddemann W, Kneba M, Kluin-Nelemans HC, Hermine O, Macintyre E, Dreyling M.

Blood. 2010 Apr 22;115(16):3215-23. doi: 10.1182/blood-2009-06-230250. Epub 2009 Dec 23.

4.

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.

Martin P, Chadburn A, Christos P, Furman R, Ruan J, Joyce MA, Fusco E, Glynn P, Elstrom R, Niesvizky R, Feldman EJ, Shore TB, Schuster MW, Ely S, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP.

Ann Oncol. 2008 Jul;19(7):1327-30. doi: 10.1093/annonc/mdn045. Epub 2008 Mar 17.

5.

Prognostic impact of monocyte count at presentation in mantle cell lymphoma.

von Hohenstaufen KA, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G, Stathis A, Ghielmini M, Stussi G, Cavalli F, Gaidano G, Zucca E.

Br J Haematol. 2013 Aug;162(4):465-73. doi: 10.1111/bjh.12409. Epub 2013 Jun 29.

PMID:
23808798
6.

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2012 Jun;87(6):604-9. doi: 10.1002/ajh.23176. Review.

7.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):971-7.

PMID:
11429225
8.

Mantle cell lymphoma in the ocular adnexal region.

Looi A, Gascoyne RD, Chhanabhai M, Connors JM, Rootman J, White VA.

Ophthalmology. 2005 Jan;112(1):114-9.

PMID:
15629830
9.

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.

Evens AM, Winter JN, Hou N, Nelson BP, Rademaker A, Patton D, Singhal S, Frankfurt O, Tallman MS, Rosen ST, Mehta J, Gordon LI.

Br J Haematol. 2008 Feb;140(4):385-93. Epub 2007 Dec 19.

PMID:
18162124
10.

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL.

Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69. Review.

PMID:
11842390
11.

Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis.

Mangel J, Leitch HA, Connors JM, Buckstein R, Imrie K, Spaner D, Crump M, Pennell N, Boudreau A, Berinstein NL.

Ann Oncol. 2004 Feb;15(2):283-90.

12.

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP.

J Clin Oncol. 2009 Dec 20;27(36):6101-8. doi: 10.1200/JCO.2009.22.2554. Epub 2009 Nov 16.

13.

Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.

Bernard M, Gressin R, Lefrère F, Drénou B, Branger B, Caulet-Maugendre S, Tass P, Brousse N, Valensi F, Milpied N, Voilat L, Sadoun A, Ghandour C, Hunault M, Leloup R, Mannone L, Hermine O, Lamy T.

Leukemia. 2001 Nov;15(11):1785-91.

PMID:
11681422
14.

The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.

Ying ZT, Zheng W, Wang XP, Xie Y, Tu MF, Lin NJ, Ping LY, Liu WP, Deng LJ, Zhang C, Zhu J, Song YQ.

Chin J Cancer. 2012 Jul;31(7):348-53. doi: 10.5732/cjc.011.10469. Epub 2012 Jun 14.

15.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
16.

Patterns of survival in mantle cell lymphoma.

Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F.

Ann Oncol. 1995 Mar;6(3):257-62.

PMID:
7612491
17.

Treatment strategies in mantle cell lymphoma.

Maddocks K, Blum KA.

Cancer Treat Res. 2015;165:251-70. doi: 10.1007/978-3-319-13150-4_10. Review.

PMID:
25655613
18.

Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2013 Dec;88(12):1082-8. doi: 10.1002/ajh.23615. Review.

19.

Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.

Koh YW, Shin SJ, Park C, Yoon DH, Suh C, Huh J.

Hematol Oncol. 2014 Dec;32(4):178-86. doi: 10.1002/hon.2106. Epub 2013 Oct 29.

PMID:
24910369
20.

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM.

Ann Oncol. 2006 Jan;17(1):123-30. Epub 2005 Oct 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk